Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Lymphoma; Lymphoma, Mantle-Cell Phase 2 ClinicalTrials
Multiple Myeloma; Neoplasms, Plasma Cell Phase 1/Phase 2 ClinicalTrials
Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid Phase 2 ClinicalTrials
CONTENTS